Profund Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,078
| Closed | -$1.47M | – | 1210 |
|
|
2023
Q4 | $1.47M | Sell |
25,078
-15,961
| -39% | -$938K | 0.06% | 249 |
|
|
2023
Q3 | $1.79M | Buy |
41,039
+2,205
| +6% | +$96.1K | 0.1% | 161 |
|
|
2023
Q2 | $1.4M | Buy |
38,834
+7,307
| +23% | +$264K | 0.08% | 228 |
|
|
2023
Q1 | $1.17M | Buy |
31,527
+25,747
| +445% | +$957K | 0.07% | 264 |
|
|
2022
Q4 | $262K | Buy |
5,780
+323
| +6% | +$14.6K | 0.02% | 735 |
|
|
2022
Q3 | $381K | Sell |
5,457
-254
| -4% | -$17.7K | 0.03% | 478 |
|
|
2022
Q2 | $383K | Sell |
5,711
-479
| -8% | -$32.1K | 0.02% | 517 |
|
|
2022
Q1 | $509K | Sell |
6,190
-626
| -9% | -$51.5K | 0.02% | 564 |
|
|
2021
Q4 | $1M | Sell |
6,816
-634
| -9% | -$93K | 0.03% | 332 |
|
|
2021
Q3 | $1.32M | Buy |
+7,450
| New | +$1.32M | 0.04% | 287 |
|
|
2021
Q2 | – | Sell |
-1,308
| Closed | -$224K | – | 1439 |
|
|
2021
Q1 | $224K | Buy |
1,308
+396
| +43% | +$67.8K | 0.01% | 1196 |
|
|
2020
Q4 | $200K | Buy |
+912
| New | +$200K | 0.01% | 1112 |
|